Primary hyperthyroidism induced erythropoietin-resistant anemia?

Internal Medicine

Volumn 36, Issue 12, 1997, Pages 903-905

  Jyo Oshiro, Yoshiyuki ^a   Nomura, Shinsuke ^a   Fukushima, Tatsuo ^a   Tamai, Hitoshi ^a   Fueki, Hisao ^b   Osawa, Gengo ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b Fueki Internal Medicine Clinic   (Japan)

Author keywords

Anti hyperthyroid therapy; Renal failure

Indexed keywords

RECOMBINANT ERYTHROPOIETIN; THIAMAZOLE;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; ERYTHROPOIESIS; HEMATOCRIT; HUMAN; MALE; PRIMARY HYPERPARATHYROIDISM; TREATMENT OUTCOME;

EID: 0031423877     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.903     Document Type: Article

References (13)

1. Eschbach JW, Adamson JW. Anemia of end-stage renal disease (ESRD). Kidney Int 28: 1, 1985.
2. Eschbach JW. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin (clinical conference). Kidney Int 35: 134, 1989.
3. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 316: 73, 1987 (see comments).
4. Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 2: 1175, 1986.
5. Drueke TB. Modulating factors in the hematopoietic response to erythropoietin. Am J Kidney Dis 18: 87, 1991.
6. Delwiche F, Garrity MJ, Powell JS, Robertson RP, Adamson JW. High levels of the circulating form of parathyroid hormone do not inhibit in vitro erythropoiesis. J Lab Clin Med 102: 613, 1983.
7. McGonigle RJ, Wallin JD, Husserl F, et al. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure. J Lab Clin Med 104: 1016, 1984.
8. Drueke TB. Resistance to recombinant human erythropoietin in hemodialysis patients. Am J Nephrol 10 Suppl 2: 34, 1990.
9. Ozono Y, Harada T, Taura K, Kawatomi M, Hara K. rHuEpo-resistant anaemia in haemodialysis patients. Nephrol Dial Transplant 9: 872, 1994 (Letter).
10. Juan D, Wehrmeister J. Diagnostic utility of carboxyl-terminal and intact parathyroid hormone immunoassays in hospitalized patients. Am J Clin Pathol 77: 720, 1982.
11. Brenner B, Fandrey J, Jelkmann W. Serum immunoreactive erythropoietin in hyper- and hypothyroidism: clinical observations related to cell culture studies. Eur J Haematol 53: 6, 1994.
12. Ogihara T, Katoh H, Yoshitake H, Iyori S, Saito I. Hyperthyroidism associated with autoimmune hemolytic anemia and periodic paralysis: a report of a case in which antihyperthyroid therapy alone was effective against hemolysis. Jpn J Med 26: 401, 1987.
13. Hinterberger-Fischer M, Kier P, Forstinger I, et al. Coincidence of severe aplastic anaemia with multiple sclerosis or thyroid disorders. Report of 5 cases. Acta Haematol 92: 136, 1994.